SPS
CNMD icon

Susquehanna Portfolio Strategies’s CONMED CNMD Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,368
Closed -$1.52M – 999
2025
Q4 		$1.52M Buy
+37,368
New +$1.63M 0.02% 562
2024
Q1 		– Sell
-4,921
Closed -$539K – 814
2023
Q4 		$539K Buy
+4,921
New +$509K 0.01% 744

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Susquehanna Portfolio Strategies's CNMD Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of CONMED (CNMD) in Q1 2026, closing a stake of 37,368 shares — an estimated $1.52M sold.

Susquehanna Portfolio Strategies first reported a position in CNMD in Q4 2023 and held it in 2 quarters. The position peaked at $1.52M in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 37,368 CONMED shares in Q1 2026, an estimated $1.52M.
  • Susquehanna Portfolio Strategies first reported a position in CONMED in Q4 2023 and held it in 2 quarters.
  • Susquehanna Portfolio Strategies's CONMED position peaked at $1.52M in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.